Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander R Lyon

Showing results (241-250 of 267) with videos related to

Pageof 27
Sort By:
European Heart Journal. Cardiovascular Imaging|August 26, 2022
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R Lyon, Teresa López-Fernández, Liam S Couch, et al.
European Journal of Heart Failure|January 27, 2022
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC, Theresa A McDonagh, Marco Metra, et al.
European Heart Journal|October 14, 2021
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESCTheresa A McDonagh, Marco Metra, Marianna Adamo, et al.
European Journal of Heart Failure|May 30, 2020
Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of CardiologyOvidiu Chioncel, John Parissis, Alexandre Mebazaa, et al.
European Journal of Heart Failure|June 18, 2025
How to facilitate seamless translation from basic concepts to new heart failure drugs. A scientific statement of the Heart Failure Association of the ESCCarlo Gabriele Tocchetti, Arantxa González, Johannes Backs, et al.
European Journal of Heart Failure|October 17, 2020
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failurePetar M Seferović, Gabriele Fragasso, Mark Petrie, et al.
Circulation|June 17, 2020
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated MyocarditisLili Zhang, Daniel A Zlotoff, Magid Awadalla, et al.
European Heart Journal|October 9, 2018
Treatments targeting inotropyChristoph Maack, Thomas Eschenhagen, Nazha Hamdani, et al.
European Journal of Heart Failure|July 4, 2020
Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of CardiologyPetar M Seferović, Gabriele Fragasso, Mark Petrie, et al.
European Journal of Heart Failure|October 2, 2020
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of CardiologyRadek Pudil, Christian Mueller, Jelena Čelutkienė, et al.
Pageof 27

Showing results (241-250 of 267) with videos related to

Sort By:
Pageof 27
European Heart Journal. Cardiovascular Imaging|August 26, 2022
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R Lyon, Teresa López-Fernández, Liam S Couch, et al.
European Journal of Heart Failure|January 27, 2022
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC, Theresa A McDonagh, Marco Metra, et al.
European Heart Journal|October 14, 2021
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESCTheresa A McDonagh, Marco Metra, Marianna Adamo, et al.
European Journal of Heart Failure|May 30, 2020
Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of CardiologyOvidiu Chioncel, John Parissis, Alexandre Mebazaa, et al.
European Journal of Heart Failure|June 18, 2025
How to facilitate seamless translation from basic concepts to new heart failure drugs. A scientific statement of the Heart Failure Association of the ESCCarlo Gabriele Tocchetti, Arantxa González, Johannes Backs, et al.
European Journal of Heart Failure|October 17, 2020
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failurePetar M Seferović, Gabriele Fragasso, Mark Petrie, et al.
Circulation|June 17, 2020
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated MyocarditisLili Zhang, Daniel A Zlotoff, Magid Awadalla, et al.
European Heart Journal|October 9, 2018
Treatments targeting inotropyChristoph Maack, Thomas Eschenhagen, Nazha Hamdani, et al.
European Journal of Heart Failure|July 4, 2020
Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of CardiologyPetar M Seferović, Gabriele Fragasso, Mark Petrie, et al.
European Journal of Heart Failure|October 2, 2020
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of CardiologyRadek Pudil, Christian Mueller, Jelena Čelutkienė, et al.
Pageof 27